引导式网络与移动认知行为疗法对慢性躯体疾病合并抑郁焦虑青少年的效果与成本效果:多中心随机对照试验方案
该多中心两臂随机对照试验计划在12-21岁患有1型糖尿病、囊性纤维化或幼年特发性关节炎且焦虑或抑郁筛查评分≥7的青少年中,评估引导式网络与移动认知行为疗法(youthCOACHCD)联合常规治疗与增强常规治疗相比的效果与成本效果,计划招募212例,主要结局为PHQ焦虑抑郁量表测量的抑郁焦虑症状严重程度。
要点
- 纳入标准为12-21岁慢性躯体疾病患者且PHQ-9或GAD-7评分≥7。
- 主要结局为PHQ焦虑抑郁量表测量的抑郁焦虑症状严重程度。
- 干预为引导式iCBT联合常规治疗,对照为增强常规治疗。
核心结论
- 该试验旨在评估引导式iCBT(youthCOACHCD)联合常规治疗对慢性躯体疾病合并抑郁焦虑青少年的效果与成本效果。
研究设计与样本
- 多中心两臂随机对照试验,计划通过德国三个患者登记处招募212例(每组106例)12-21岁患者。
- 纳入三种慢性躯体疾病(1型糖尿病、囊性纤维化或幼年特发性关节炎)且PHQ-9和/或GAD-7筛查评分≥7的青少年。
- 评估时间点为基线及随机化后6周、3个月、6个月和12个月。
关键数值与推荐
- 主要结局为PHQ焦虑抑郁量表测量的抑郁焦虑症状严重程度。
- 次要结局包括健康相关生活质量、应对策略、自我效能、压力相关个人成长、社会支持、行为激活、适应与创伤相关症状、自动思维、干预满意度、工作联盟和互联网使用。
- 将进行成本效果分析,并探索干预效果的潜在调节因素和中介因素。
临床怎么用
- 该研究将iCBT直接整合到常规协作医疗中,为医疗政策与利益相关者提供将iCBT纳入现有医疗系统的见解。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Adolescents and young adults (AYA) with chronic somatic conditions have an increased risk of comorbid depression and anxiety symptoms. Internet- and mobile-based cognitive behavioural therapy (iCBT) might be one possibility to extend the access to evidence-based treatments. Studies suggest that guided iCBT can reduce anxiety and depression symptoms in AYA. However, little is known about the effectiveness of iCBT for AYA with chronic somatic conditions and comorbid symptoms of anxiety and/or depression in routine care. Evidence on the (cost-)effectiveness of iCBT is essential for its implementation in health care. OBJECTIVES AND METHODS: This multicentre two-armed randomized controlled trial (RCT) aims to evaluate the (cost-) effectiveness of guided iCBT (youthCOACHCD) in addition to treatment as usual (TAU) compared to enhanced treatment as usual (TAU+) in AYA aged 12-21 years with one of three chronic somatic conditions (type 1 diabetes, cystic fibrosis, or juvenile idiopathic arthritis). AYA with one of the chronic somatic conditions and elevated symptoms of anxiety or depression (Patient Health Questionnaire [PHQ-9] and/or Generalized Anxiety Disorder [GAD-7] Screener score ≥ 7) will be eligible for inclusion. We will recruit 212 patients (2 × n = 106) in routine care through three German patient registries. Assessments will take place at baseline and at 6 weeks, 3 months, 6 months, and 12 months post-randomization. The primary outcome will be combined depression and anxiety symptom severity as measured with the PHQ Anxiety and Depression Scale. Secondary outcomes will include health-related quality of life, coping strategies, self-efficacy, stress-related personal growth, social support, behavioural activation, adjustment and trauma-related symptoms, automatic thoughts, intervention satisfaction, working alliance, and Internet usage. The cost-effectiveness will be determined, and potential moderators and mediators of intervention effects will be explored. DISCUSSION: iCBT might implicate novel ways to increase the access to evidence-based interventions in this specific population. The distinct focus on effectiveness and cost-effectiveness of youthCOACHCD in patients with chronic somatic conditions, as well as intervention safety, will most likely provide important new insights in the field of paediatric e-mental health. A particular strength of the present study is its implementation directly into routine collaborative health care. As such, this study will provide important insights for health care policy and stakeholders and indicate how iCBT can be integrated into existing health care systems. TRIAL REGISTRATION: German Clinical Trials Register (DRKS), DRKS00017161. Registered on 17 September 2019.
引用
- Lunkenheimer F, Domhardt M, Geirhos A, et al. Effectiveness and cost-effectiveness of guided Internet- and mobile-based CBT for adolescents and young adults with chronic somatic conditions and comorbid depression and anxiety symptoms (youthCOACHCD): study protocol for a multicentre randomized controlled trial. Trials. 2020. PMID: 32164723. doi:10.1186/s13063-019-4041-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。